Related Experiment Video
Updated: Apr 4, 2026
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
13.4K
Optimising gut colonisation resistance against Clostridium difficile infection
S Yuille1, W G Mackay2, D J Morrison3
1School of Science, University of the West of Scotland, Hamilton Campus, Almada Street, Hamilton, ML3 0JB, UK.
Summary
Clostridium difficile infection (CDI) is a significant healthcare challenge, especially for elderly patients. This review explores the colonisation resistance barrier as a novel strategy to prevent and treat CDI.
Area of Science:
- Microbiology
- Gastroenterology
- Infectious Diseases
Background:
- Clostridium difficile is a primary cause of nosocomial pseudomembranous colitis.
- Clostridium difficile infection (CDI) disproportionately affects elderly inpatients with prior broad-spectrum antibiotic use.
- High rates of CDI reinfection and relapse lead to substantial economic burden and healthcare costs.
Purpose of the Study:
- To review existing evidence supporting the colonisation resistance barrier against CDI.
- To explore potential alternative strategies for CDI prevention and treatment in high-risk individuals.
- To highlight the role of metagenomics in understanding and optimizing the colonisation resistance barrier.
Main Methods:
- Literature review of studies investigating factors influencing Clostridium difficile growth and toxin production.
- Analysis of in vitro and in vivo data related to colonisation resistance mechanisms.
- Synthesis of current understanding of metagenomics in the context of CDI.
Main Results:
- Factors such as pH, oxidation-reduction potentials, and short-chain fatty acids demonstrate inhibitory effects on C. difficile growth and toxin production.
- Metagenomics offers insights into the complex interactions within the gut microbiome that contribute to colonisation resistance.
- The review consolidates evidence for the protective role of a robust colonisation resistance barrier.
Conclusions:
- Optimizing the colonisation resistance barrier presents a promising avenue for preventing and treating CDI.
- Further research into modulating gut microbiota and environmental factors is crucial for developing novel CDI therapies.
- Addressing CDI requires exploring alternatives beyond traditional antibiotics and fecal transplantation.
Related Concept Videos
01:18Functions of the Gut Microbiota
54
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
54
01:30Development of Human Microbiota
36
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
36
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
546
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
546
01:22Probiotics
221
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
221
01:27Microbiota of the Stomach and Small Intestine
43
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
43
01:25Colonisation of Pathogens
39
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
39